Atreides doubled its Astera Labs stake to $875 million, then the stock fell 43%
The 13F, filed November 16, marks the stake at September 30; the stock has since fallen 43%. The next look at who owns it arrives with the mid-February filings, in the same month as the fourth-quarter results, so the September register is the one every rally trades against.
Vincent Jiangthree-minute read
The September buyers are on the record
Atreides Management, a Boston firm managing $10.7 billion, doubled its Astera Labs+1.82% — Astera Labs, up 1.82 percent today holding to 2.46 million shares in the third quarter: $875 million at September 30, 8.1% of its disclosed US stock book and its second-largest line after a $4.1 billion SpaceX+1.07% — SpaceX, up 1.07 percent today stake 12. The filing counts 2,459,106 shares exactly, and carries puts on a semiconductor ETF reported at $1.2 billion alongside the chip longs 2.
E20 Capital, with $1.21 billion of disclosed US stocks, filed November 13 showing a new 268,570-share stake worth $96 million, its third-largest line 3. Whale Rock Capital, at nearly $13 billion, had sold all 1.57 million of its Astera shares by the same date 1.
From $100 to $483 and back to $202
The shares ran from a closing low of $100.27 on March 30 to a 52-week high of $483.02 on June 30, then closed at $202.34 on November 16, down 43% since September 30 though still up 40% over twelve months 41. The implied entry on the filings, reported value divided by share count, is about $356 2.
Astera Labs peaked at $483 in June and closed near $212 on November 17
The September 30 mark, where two funds added, sits halfway down the slide
Data
| ALAB share price | |
|---|---|
| Mar 30 | $100.27 |
| Jun 30 | $483.02 |
| Nov 16 | $202.34 |
| Nov 17 | $211.6 |
If the shares are still there, the hole is $378 million
A 13F, the quarterly holdings snapshot funds file with the SEC, shows one day: no purchase prices, no current holdings 1. Marked to the November 16 close, Atreides' line is worth about $498 million, a paper decline near $378 million on one position; E20's $96 million is nearer $54 million 1.
Passive money is leaving through the same door: ETFs net sold $42.3 million of Astera on Friday, November 13, and $27.9 million the day before, led by the iShares Semiconductor fund SOXX cutting 281,295 shares, 7.66% of its stake 5. The retreat is not universal: 31 ETFs bought against 10 sellers, and November 9's 13.7% rally drew $96.0 million of net ETF buying, the largest one-day move of the stretch 5.
ETF flows into Astera flipped from buying to net selling
Passive money bought the rally, then turned seller
Data
| ETF net flows into ALAB | |
|---|---|
| Nov 9 | $96M |
| Nov 11 | $15.2M |
| Nov 12 | -$27.9M |
| Nov 13 | -$42.3M |
The ramp is real, and the price still needs it
Third-quarter revenue was $584.9 million, up 153.7% year over year, with the fourth quarter guided to $730 million to $750 million, about 27% more than the third at the midpoint 67. Scorpio switches, now the largest product family, run above $1 billion annualized, with Scorpio X volume still shipping to two customers 63, the concentration covered here on November 4.
Revenue grew sevenfold from mid-2024, and the fourth quarter is guided 27% higher
- Quarterly revenue
- Estimate
Data
| Quarterly revenue | |
|---|---|
| Q2 '24 | $76.85M |
| Q3 '24 | $113.09M |
| Q4 '24 | $141.1M |
| Q1 '25 | $159.44M |
| Q2 '25 | $191.93M |
| Q3 '25 | $230.58M |
| Q4 '25 | $270.58M |
| Q1 '26 | $308.36M |
| Q2 '26 | $392.4M |
| Q3 '26 | $584.9M |
| Q4 '26 guide (estimate) | $740M ($730–750M) |
The stock still fell 8.8% on November 16, the day Astera and Hyve Solutions, TD SYNNEX's manufacturing arm, said Hyve will build Orion's compute board, fabric tray and link board, company-tested at up to 89% more tokens per second and available from the first quarter of 2027 8. Tuesday brought a 4.6% bounce to $211.60 9.
At $36.1 billion of market value, about 12 times annualized fourth-quarter revenue, the price still assumes the ramp lands 10.
Both verdicts land in February
Twenty-five analysts carry a mean Buy and a $344.15 average target, 63% above Tuesday's close, after RBC cut its target to $400 from $500 and UBS to $290 9. That case is about the ramp; the register is its own problem. The next 13Fs are due mid-February, the same month as the fourth-quarter report, so who is still holding stays invisible until the evidence is in 9. The September buyers are the sellers of any rally.
Get Chips by email, free
How AI demand is reshaping chipmakers, memory and the fabs behind them. In our daily email, every weekday.






Reader comments
0 comments